ZERIA PHARMACEUTICAL CO.,LTD., First Half Ordinary Profit Revised Upward by 42%, Adds to Record High Profit Forecast, Full Year also Increased

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Tue Nov 5, 2024 11:00 am JST Revision

4559 ZERIA PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Guidance Update Report

ZERIA PHARMACEUTICAL CO.,LTD. <4559> [TSE-P] announced a performance revision in the morning on November 5th (11:00). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2025 (April to September) has been revised upward by 41.8%, from the previous forecast of 5.6 billion yen to 7.94 billion yen (compared to 5.49 billion yen in the same period of the previous year), increasing the growth rate from 1.9% to 44.5%, further surpassing the previous forecast of record-high profits for three consecutive terms.

Following the strong performance in the first half, the full-year consolidated ordinary profit has been revised upward by 10.0%, from the previous forecast of 10 billion yen to 11 billion yen (compared to 8.51 billion yen in the previous period), increasing the growth rate from 17.5% to 29.2%, further surpassing the previous forecast of record-high profits for three consecutive terms.

Kabutan News

Guidance Update

First Half Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Apr - Sep, 2024 Prev	41,000	5,600	5,600	4,300	97.6	23	May 9, 2024	J-GAAP
Apr - Sep, 2024 New	42,420	6,450	7,940	6,060	137.5	23	Nov 5, 2024	J-GAAP
Revision Rate	+3.5%	+15.2%	+41.8%	+40.9%	+40.9%

Full Year Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2025 Prev	83,000	10,000	10,000	7,800	177.0	46	May 9, 2024	J-GAAP
Mar, 2025 New	86,000	11,000	11,000	8,500	192.8	46	Nov 5, 2024	J-GAAP
Revision Rate	+3.6%	+10.0%	+10.0%	+9.0%	+9.0%

Current Period Guidance

H1 Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Apr - Sep, 2023	36,678	5,327	5,495	5,396	122.4	22	Nov 1, 2023	J-GAAP
Apr - Sep, 2024 Guidance	42,420	6,450	7,940	6,060	137.5	23	Nov 5, 2024	J-GAAP
YoY	+15.7%	+21.1%	+44.5%	+12.3%	+12.3%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	68,383	9,014	7,579	6,195	140.3	40	May 11, 2023	J-GAAP
Mar, 2024	75,725	9,621	8,513	7,731	175.4	44	May 9, 2024	J-GAAP
Mar, 2025 Guidance	86,000	11,000	11,000	8,500	192.8	46	Nov 5, 2024	J-GAAP
YoY	+13.6%	+14.3%	+29.2%	+9.9%	+9.9%